Clinical trial
Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection
NCT00043355 · InterMune, Industry · Terminated
Key facts
| NCT number | NCT00043355 |
|---|---|
| Title | Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Safety and Efficacy of Inhaled Interferon Gamma-1b With Antimycobacterials in Previously Treated or Mod-to-Sev Pulmonary Mycobacterium Avium Complex Infection |
| Lead sponsor | InterMune, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Infection |
| Intervention type | Drug |
| Interventions | interferon gamma-1b |
| Enrollment | 100 |
| Start date | Dec 1, 2000 |
| Completion | Feb 1, 2003 |
| First posted | Aug 12, 2002 |
| Last update posted | Nov 1, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: